Eagle Pharmaceuticals (EGRX) Fails to deliver data

Key failure to deliver metrics for Eagle Pharmaceuticals :

• Last SEC data release: 2026-01-14
• Last 15 days FTD volume: A$0 M
• Last 3 months FTD volume: A$0 M
• Last 12 months FTD volume: A$0.22 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Eagle Pharmaceuticals (EGRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Eagle Pharmaceuticals (EGRX) - since 2014

Eagle Pharmaceuticals (EGRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Johnson & Johnson JNJ	A$24.94 M	A$0.10 B	🇺🇸 USA
Novartis NVS	A$93.01 M	A$0.15 B	🇨🇭 Switzerland
Eli Lilly LLY	A$0.20 B	A$0.41 B	🇺🇸 USA
Amgen AMGN	A$0.20 B	A$0.37 B	🇺🇸 USA
Bristol-Myers Squibb BMY	A$31.05 M	A$81.93 M	🇺🇸 USA
GSK plc GSK	A$48.95 M	A$0.36 B	🇬🇧 UK
Teva Pharmaceutical Industries TEVA	A$53.08 M	A$87.14 M	🇮🇱 Israel